The interaction of regulated forms of cell death in the pathogenesis of severe facial paralysis and potential therapeutic strategies

Xing Tang, Zhen Ji, Xueling Xiao, Tongtong Zhu, Shou‐Jen Lan, Yea‐Yin Yen, Xin Shao, Shune Tan, Chao Wang, Jicheng ZhangFrontiers in Neuroscience 2025 · DOI

Abstract

Neuronal cell death plays a central role in the pathogenesis of facial paralysis. In the constructed severe facial paralysis model, axonal damage becomes the key factor triggering retrograde neuronal degeneration, resulting in a large number of neuronal deaths, which seriously affects the function of the facial nerve. The basic fibroblast growth factor (bFGF) exhibits strong neuroprotective ability and can significantly reduce the neuronal mortality rate, providing a strong guarantee for neuronal survival. Viral infection is also an important pathogenic factor; viruses such as herpes simplex virus type 1 (HSV-1) can trigger neuroinflammation through the immune response, further exacerbating nerve damage. However, recent studies have also brought hope. Neural reconstruction techniques, targeted drugs, and stem cell therapies hold potential value in promoting the recovery of damaged neural functions. These research results reveal that multiple factors affect the survival and function of neurons in facial paralysis through different pathways, laying a theoretical foundation for targeted treatment against neuronal death. In the future, developing new therapies based on these mechanisms will bring new treatment opportunities for patients with severe facial paralysis, potentially improving their prognosis and significantly enhancing their quality of life.

Introduction: The Challenge of Severe Facial Paralysis

Facial paralysis is a debilitating condition that significantly impacts a patient's quality of life and social function. While many cases are manageable, severe facial paralysis often fails to respond to conventional treatments like corticosteroids. The clinical challenge lies in the molecular "decision-making" process of neurons following injury. When the facial nerve is compromised—whether through trauma, ischemia, or viral infection—a distress signal travels backward from the injury site to the cell body, a process known as retrograde degeneration. If this cascade is not interrupted, the neuron undergoes regulated cell death (RCD), leading to permanent functional loss.

Classification of facial paralysis types, causes, and potential therapeutic strategies.

Pathogenic Mechanisms: The "Vicious Cycle" of Cell Death

Recent advances in molecular biology have shifted the focus from simple nerve damage to the complex interplay of RCD pathways, including apoptosis, necroptosis, and ferroptosis. Cell death in the facial nerve is not a isolated event but a cascade.

Axonal damage triggers an excessive influx of calcium ions, which destroys cell structure and activates proteases. While apoptosis is the primary driver of early neuronal loss, necroptosis and ferroptosis contribute to secondary injury by releasing Damage-Associated Molecular Patterns (DAMPs). These DAMPs trigger a pro-inflammatory immune response, involving factors like TNF-α and IL-1β, which further damages nerve cells and disrupts the blood-brain barrier. This creates a "vicious cycle" where inflammation and cell death reinforce one another.

Key molecular mechanisms and their impact on neural injury and inflammation.

Diagnostic and Therapeutic Innovations

To address these mechanisms, researchers are evaluating both diagnostic precision and novel interventions. Electrophysiological tools like Neuroelectrography (ENoG) have become essential for predicting prognosis; a significant reduction in wave amplitude serves as a primary indicator of RCD-driven neurodegeneration.

Neuroprotective and Regenerative Strategies

  • Growth Factors: In freezing-induced models of facial paralysis, the neuronal death rate was recorded at 29%. The administration of basic fibroblast growth factor (bFGF) significantly reduced this rate to 15.8%, demonstrating a potent ability to enhance neuronal survival.
  • Hormonal Rescue: Sex steroids, including testosterone and estradiol, have shown the potential to rescue approximately 20% of motor neurons following axon transection.
  • Stem Cell Therapy: Mesenchymal stem cells (MSCs) and adipose-derived stem cells (ADSCs) act as "bio-factories," secreting nerve growth factors (NGF) and anti-inflammatory cytokines that facilitate axonal regeneration and modulate the immune environment.
  • Surgical Reconstruction: For intractable cases, neural reconstruction techniques such as nerve transplantation and anastomosis remain critical for restoring physical continuity and function.

Future Directions and Limitations

Despite the promise of these molecular insights, several hurdles remain. Most high-potential treatments, such as bFGF and stem cell therapies, are currently in the preclinical stage. There is a pressing need for large-scale human trials and a standardized system for evaluating long-term efficacy. Furthermore, the "therapeutic window" for intervention—especially in viral-induced cases—is narrow; future research must focus on precise, targeted drug delivery systems to intervene before retrograde degeneration becomes irreversible. By refining these strategies, clinicians can move toward a more personalized and effective approach to treating severe facial paralysis.

Summary updated

Abstract

Neuronal cell death plays a central role in the pathogenesis of facial paralysis. In the constructed severe facial paralysis model, axonal damage becomes the key factor triggering retrograde neuronal degeneration, resulting in a large number of neuronal deaths, which seriously affects the function of the facial nerve. The basic fibroblast growth factor exhibits strong neuroprotective ability and can significantly reduce the neuronal mortality rate, providing a strong guarantee for neuronal survival. Viral infection is also an important pathogenic factor that cannot be ignored. Viruses such as herpes simplex virus type 1 can trigger neuroinflammation through the immune response, further exacerbating nerve damage. However, recent studies have also brought hope. Neural reconstruction techniques, targeted drugs, and stem cell therapies hold potential value in promoting the recovery of damaged neural functions. These research results reveal that multiple factors affect the survival and function of neurons in facial paralysis through different pathways, laying a theoretical foundation for targeted treatment against neuronal death. In the future, based on these mechanisms, developing new therapies will bring new treatment opportunities for patients with severe facial paralysis, potentially improving their prognosis and significantly enhancing their quality of life, with important clinical value.
BibTeX
@inproceedings{tang2025interaction,
  author = {Xing Tang and Zhen Ji and Xueling Xiao and Tongtong Zhu and Shou‐Jen Lan and Yea‐Yin Yen and Xin Shao and Shune Tan and Chao Wang and Jicheng Zhang},
  title = {{The interaction of regulated forms of cell death in the pathogenesis of severe facial paralysis and potential therapeutic strategies}},
  booktitle = {Frontiers in Neuroscience},
  year = {2025},
  doi = {10.3389/fnins.2025.1720961},
}
Figure